BR0308305A - Fórmulas dosadas de liberação controlada - Google Patents
Fórmulas dosadas de liberação controladaInfo
- Publication number
- BR0308305A BR0308305A BR0308305-5A BR0308305A BR0308305A BR 0308305 A BR0308305 A BR 0308305A BR 0308305 A BR0308305 A BR 0308305A BR 0308305 A BR0308305 A BR 0308305A
- Authority
- BR
- Brazil
- Prior art keywords
- zero
- order
- controlled release
- metered
- dosed
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 4
- 239000007787 solid Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36182102P | 2002-03-04 | 2002-03-04 | |
| US29161902A | 2002-11-12 | 2002-11-12 | |
| PCT/US2003/006591 WO2003075893A1 (en) | 2002-03-04 | 2003-03-03 | Controlled release dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0308305A true BR0308305A (pt) | 2004-12-28 |
Family
ID=27807664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0308305-5A BR0308305A (pt) | 2002-03-04 | 2003-03-03 | Fórmulas dosadas de liberação controlada |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1492508A4 (enExample) |
| JP (1) | JP2005524670A (enExample) |
| KR (1) | KR20100049695A (enExample) |
| CN (1) | CN1649569B (enExample) |
| AU (2) | AU2003217909C1 (enExample) |
| BR (1) | BR0308305A (enExample) |
| CA (1) | CA2477701A1 (enExample) |
| EA (1) | EA005866B1 (enExample) |
| IL (1) | IL163887A0 (enExample) |
| MX (1) | MXPA04008536A (enExample) |
| NO (1) | NO20044188L (enExample) |
| NZ (1) | NZ535083A (enExample) |
| WO (1) | WO2003075893A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
| RU2005104827A (ru) * | 2002-07-19 | 2006-07-27 | Рэнбакси Лабораториз Лимитед (In) | Таблетки суматриптана с замаскированным вкусом и способы их получения |
| US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| US20040122065A1 (en) * | 2002-11-12 | 2004-06-24 | Lerner E. Itzhak | Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccally |
| EP1698448B1 (en) * | 2003-11-14 | 2017-01-18 | Sanwa Kagaku Kenkyusho Co., Ltd. | Method of manufacturing nucleated molding |
| GB0400452D0 (en) * | 2004-01-09 | 2004-02-11 | Norton Healthcare Ltd | A pharmaceutical composition |
| GB0403628D0 (en) * | 2004-02-18 | 2004-03-24 | Arrow Group Ltd | Compression-coated tablets and the manufacture thereof |
| CN1921866A (zh) * | 2004-02-19 | 2007-02-28 | 特瓦制药工业有限公司 | 使用雷洛昔芬和阿伦膦酸盐的改善的联合治疗 |
| KR100701409B1 (ko) | 2004-11-26 | 2007-03-30 | 한국유나이티드제약 주식회사 | 호박산 수마트립탄을 함유하는 약제학적 조성물 |
| ES2740360T3 (es) | 2008-08-15 | 2020-02-05 | Assertio Therapeutics Inc | Composiciones farmacéuticas de retención gástrica para el tratamiento y la prevención de trastornos del SNC |
| CN103948556A (zh) * | 2014-04-08 | 2014-07-30 | 闻晓光 | 一种新型控释片 |
| JP6878417B2 (ja) * | 2016-02-17 | 2021-05-26 | トリアステック インコーポレイテッド | 剤形およびそれらの使用 |
| CN110604724A (zh) * | 2019-10-22 | 2019-12-24 | 恒诚制药集团淮南有限公司 | 一种肠溶美沙拉秦缓释片剂及其制备方法 |
| PE20251521A1 (es) | 2022-10-13 | 2025-06-05 | Clarke Mosquito Control Products Inc | Composiciones de tabletas insecticidas |
| JP2024083720A (ja) * | 2022-12-12 | 2024-06-24 | パナソニックＩｐマネジメント株式会社 | 水処理用徐放性固形薬剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB972128A (en) * | 1960-01-21 | 1964-10-07 | Wellcome Found | Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets |
| JPS61243016A (ja) * | 1985-04-19 | 1986-10-29 | Katsumi Takada | 柱状の有効成分含有部分をもつ錠剤 |
| GB8514666D0 (en) * | 1985-06-11 | 1985-07-10 | Coopers Animal Health | Agent delivery systems |
| JPS6253918A (ja) * | 1985-09-02 | 1987-03-09 | Katsumi Takada | 柱状の有効成分含有部分を埋没させた錠剤 |
| DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
| US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
| JP3962108B2 (ja) * | 1995-04-03 | 2007-08-22 | 中外製薬株式会社 | スクラルファート含有製剤組成物 |
| CA2184316A1 (en) * | 1995-09-12 | 1997-03-13 | Wei-Chi Liao | Buccal delivery system for therapeutic agents |
| SI0931543T1 (en) * | 1997-12-19 | 2002-10-31 | Merck Patent Gmbh | Multilayered tablet comprising probiotic microorganisms such as lactobacilli or bifidobacteria |
| NZ504834A (en) * | 1997-12-22 | 2001-12-21 | Schering Corp | Tricyclic amide molecular dispersion composition with enhanced bioavailability |
| JP4748839B2 (ja) * | 1999-03-25 | 2011-08-17 | 大塚製薬株式会社 | シロスタゾール製剤 |
| US6499984B1 (en) * | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
| MXPA03000194A (es) * | 2000-06-28 | 2004-09-13 | Angiogenix Inc | Formulaciones de arginina de liberacion controlada. |
| EA006053B1 (ru) * | 2001-12-24 | 2005-08-25 | Тева Фармасьютикал Индастриес Лтд. | Твёрдая лекарственная форма, способ её изготовления и устройство |
-
2003
- 2003-03-03 KR KR1020107008536A patent/KR20100049695A/ko not_active Ceased
- 2003-03-03 CN CN038101068A patent/CN1649569B/zh not_active Expired - Fee Related
- 2003-03-03 CA CA002477701A patent/CA2477701A1/en not_active Abandoned
- 2003-03-03 JP JP2003574168A patent/JP2005524670A/ja active Pending
- 2003-03-03 NZ NZ535083A patent/NZ535083A/en not_active IP Right Cessation
- 2003-03-03 BR BR0308305-5A patent/BR0308305A/pt not_active IP Right Cessation
- 2003-03-03 AU AU2003217909A patent/AU2003217909C1/en not_active Ceased
- 2003-03-03 IL IL16388703A patent/IL163887A0/xx unknown
- 2003-03-03 WO PCT/US2003/006591 patent/WO2003075893A1/en not_active Ceased
- 2003-03-03 MX MXPA04008536A patent/MXPA04008536A/es active IP Right Grant
- 2003-03-03 EP EP03713882A patent/EP1492508A4/en not_active Withdrawn
- 2003-03-03 EA EA200401097A patent/EA005866B1/ru not_active IP Right Cessation
-
2004
- 2004-10-01 NO NO20044188A patent/NO20044188L/no not_active Application Discontinuation
-
2009
- 2009-01-30 AU AU2009200353A patent/AU2009200353A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL163887A0 (en) | 2005-12-18 |
| WO2003075893A1 (en) | 2003-09-18 |
| AU2003217909A1 (en) | 2003-09-22 |
| JP2005524670A (ja) | 2005-08-18 |
| NZ535083A (en) | 2007-06-29 |
| MXPA04008536A (es) | 2005-09-08 |
| AU2003217909B2 (en) | 2008-10-30 |
| AU2009200353A1 (en) | 2009-02-19 |
| EP1492508A4 (en) | 2009-05-06 |
| CN1649569B (zh) | 2010-05-05 |
| CA2477701A1 (en) | 2003-09-18 |
| NO20044188L (no) | 2004-12-03 |
| AU2003217909C1 (en) | 2009-06-11 |
| EA005866B1 (ru) | 2005-06-30 |
| KR20100049695A (ko) | 2010-05-12 |
| CN1649569A (zh) | 2005-08-03 |
| EA200401097A1 (ru) | 2005-04-28 |
| EP1492508A1 (en) | 2005-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0215413A (pt) | Formula dosada com um comprimido central de ingrediente ativo encapado em uma capa anular prensada de material em pó ou granulado e processo e conjunto de ferramentas para a sua produção | |
| ES2217410T3 (es) | Forma de dosificacion oral de rapida desintegracion. | |
| SE9804314D0 (sv) | New pharmaceutical formulation | |
| BRPI0518266A2 (pt) | medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular | |
| JP5336553B2 (ja) | 正確な用量分割機能を有する製剤 | |
| KR20120112644A (ko) | 록소프로펜 함유 의약 조성물 | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| JP6009967B2 (ja) | 固形製剤 | |
| IS7006A (is) | Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd | |
| NO20071044L (no) | Doseformer med enteraltbelagte tablettkjerner | |
| EA200401097A1 (ru) | Лекарственная форма с регулируемым высвобождением активного ингредиента | |
| BR9807992A (pt) | Comprimidos para engolir os quais compreendem paracetamol | |
| AP2003002763A0 (en) | Controlled release formulations for oral administration | |
| BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
| JP7523879B2 (ja) | 医薬組成物 | |
| PE20030830A1 (es) | Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea | |
| BRPI0407438A (pt) | Sistema terapêutico compreendendo amoxicilina e ácido clavulânico | |
| JP2018100259A (ja) | 固形製剤 | |
| TWI762450B (zh) | 超高速崩解錠劑及其製造方法 | |
| TWI731846B (zh) | 超高速崩解錠劑及其製造方法 | |
| US20190350883A1 (en) | Pharmaceutical Composition of Acetaminophen/Ibuprofen | |
| JP6485120B2 (ja) | 固形製剤 | |
| US20080063709A1 (en) | Pharmaceutical compositions having novel scoring patterns | |
| JP2004331660A5 (enExample) | ||
| Saha | Immediate release drug delivery systems: a current update |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. A61K 31/195, 31/216, 31/4045, 31/433, 31/663, 45/06, 47/10, 47/16, 47/22, 47/26, 47/32, 47/34, 47/38, 9/20, 9/22, 9/24, 9/26; A61P 19/00, 25/00, 5/00, 9/00 Ipc: A61K 31/195 (2011.01), A61K 31/216 (2011.01), A61K |
|
| B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A, 10A E 11A ANUIDADES. |
|
| B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A, 16A E 17A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |